HIGHLIGHTS
- who: UPLC-/ et al. from the School of Pharmacy and Pharmaceutical Sciences, Shandong First Medical University, Jinan, China, Institute of Materia have published the research work: A Pyridazinone Compound for Effectively Treating Non-alcoholic Steatohepatitis by Targeting THR u03b2, in the Journal: (JOURNAL)
- how: The results showed that its metabolite acetaminophen appeared in a time-dependent manner.
SUMMARY
Nonalcoholic fatty liver disease (NAFLD) is characterized by heterotopic liver fat and steatosis (Dibba et_al, 2018; Pierantonelli and Svegliati, 2019). A few studies (Hannah et_al, 2016; Friedman et_al, 2018a; Kefala and Tziomalos, 2019 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.